Pazopanib for the treatment of renal cancer

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.7, 2011-05, pp. : 1171-1189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pazopanib for the treatment of breast cancer

By Amiri-Kordestani Laleh Tan Antoinette R Swain Sandra M

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 217-225

Informa Healthcare

Access to resources Recommend Favorite

Pazopanib: The Newest Tyrosine Kinase Inhibitor for the Treatment of Advanced or Metastatic Renal Cell Carcinoma

By Keisner Sidney V. Shah Sachin R.

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 443-454

Adis International

Access to resources Recommend Favorite

Treatment options in renal cancer

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Sorafenib for the treatment of renal cancer

By Strumberg Dirk

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 407-419

Informa Healthcare

Access to resources Recommend Favorite

Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report

Current Drug Targets, Vol. 17, Iss. 15, 2016-12 ,pp. : 1755-1760

Bentham Science Publishers

Access to resources Recommend Favorite